Global Sexually Transmitted Diseases Diagnostics Market Insights Forecasts to 2032

• The Sexually Transmitted Diseases Diagnostics Market Size was valued at USD 3.9 Billion in 2021.
• The market is growing at a CAGR of 8% from 2022 to 2032
• The global Sexually Transmitted Diseases Diagnostics Market is expected to reach USD 7.6 billion by 2032
• Asia Pacific is expected to grow the fastest during the forecast period

The Global Sexually Transmitted Diseases Diagnostics Market Size is expected to reach USD 7.6 billion by 2032, at a CAGR of 7.6% during the forecast period 2022 to 2032.

STD stands for sexually transmitted diseases, also known as venereal diseases (VDs), which are typically communicated by the use of contaminated needles for drugs, breastfeeding or giving birth to a baby, blood transfusions, and sexual activity. These illnesses do not have any symptoms and are only discovered through various testing such as blood tests, urine samples, or fluid samples. Antibiotics and antiviral medications can be used to treat STDs brought on by bacteria. Absorbance microplate readers, flow cytometers, scattering machines, and immunochromatographic assays are a few of the tools utilised to identify the condition.

Impact of COVID 19 On Global Sexually Transmitted Diseases Diagnostics Market

The COVID 19 pandemic is anticipated to have witness a significant impact on sexually transmitted diseases diagnostics market on a global basis. As per the Quest Diagnostics 2020 Health Trends, the screening rates for health issues like chlamydia and gonorrhea reduced at the time of pandemic and the cases of COVID 19 have increased substantially. In fact, the researchers have also found that screening and testing for sexually transmitted diseases have reduced by 63% for men as well as 59% for women at the early phases of pandemic.

Key Market Drivers

The demand for sexually transmitted disease diagnostics is going to increase as the awareness related STD diseases increases among people towards the infection which boosts the sexually transmitted diseases diagnostics market share over the forecast period. The sexually transmitted diseases diagnostics market share is mainly driven by the increasing patient check ups, government initiatives, campaigns, as well as growing awareness related to the infection and others. Over the past few years, the sexually transmitted diseases diagnostics market share has witnessed a significant rise due to advancements in the sexually transmitted diseases diagnostics devices. Apart from this, various other reasons which are propelling the growth of the market are the increasing patient education and public awareness. Moreover, the demand for sexually transmitted diseases diagnostics is anticipated to drive the market owing to an increasing cases of STDs, increasing initiatives taken by the government, and increasing patient awareness through education programs. The sexually transmitted diseases diagnostics market is anticipated to increase on a significant rate due to the increasing number of technologically improved diagnostics tools which offer more precise testing findings.

Market Segmentation

Type Insights

Chlamydia Testing segment is dominating the market over the forecast period

On the basis of type, the global sexually transmitted diseases diagnostics market is segmented into Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, Herpes Simplex Virus Testing, Human Immunodeficiency Virus Testing, Human Papilloma Virus Testing, Chancroid Testing. Among these, Chlamydia Testing segment is dominating the market with the largest market share over the forecast period. The segment is anticipated to witness the growth due to the increasing cases of different infections like syphilis, chlamydia,  herpes simplex  virus, gonorrhea, human papillomavirus, chancroid, immunodeficiency virus, and other infections  which trichomonas vaginitis and vaginitis.

Location of Testing Insights

Laboratory testing segment holds the largest market share over the forecast period

Based on location of testing, the global sexually transmitted diseases diagnostics market is laboratory testing and point of care testing. Among these, laboratory testing is dominating the market with the largest market share over the forecast period. Laboratory testing is complicated process though more precise method is involved  public health labs and private or commercial labs. Though the point of care testing comprises testing kits which is more rapid which outcomes may not be accurate.

Testing Devices Insights

Laboratory devices segment to dominate the market over the forecast period

On the basis of testing devices, the globally sexually transmitted diseases diagnostics market is segmented into laboratory devices and point of care devices. Among these, the laboratory devices comprise thermal cyclers – lateral flow readers. PCR, differential light scattering machines, flow cytometers, and absorbance microplate reader. The point of care testing devices segment, on the other hand is anticipated to witness the fastest market growth over the forecast period due to the increasing product launches.

Regional Insights

North America is dominating the market with the largest market share over the forecast period

North America is dominating the market with the largest market share over the forecast period. An increase in the acceptance of technologically advanced items is a sign of industry progress. Additionally, over the projection period, industry growth will be fueled by the emergence of novel POC testing concepts, public health laboratories offering reliable STD testing services, and insurance coverage. North America now holds a monopoly on the global market for diagnosing sexually transmitted illnesses due to the existence of public healthcare insurance programmes that encourage healthcare awareness among the populace. The availability of sophisticated diagnostic tools for STDs that have received FDA approval further contributes to the market's expansion.

Asia Pacific, on the other hand is witnessing the fastest market growth over the forecast period. Driving reasons include rising rates of sexually transmitted infections in Asia Pacific's impoverished nations as well as the economic affluence in these areas, which supports the development of diagnostics for STDs.

Recent Market Developments

• In April 2019, Quest Diagnostics has made an announcement about the launch od three new test kits for the STD which the customers can order and purchase directly online.

List of Key Companies

• Abbott
• Aposcience
• BD
• Biocartis
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Cepheid
• Danaher
• DiaSorin
• GenMark Diagnostics, Inc.
• Hologic Inc.
• OraSure Technologies, Inc.
• Qualigen Inc
• Quidel Corporation
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc
• MedMira Inc.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global Sexually Transmitted Diseases Diagnostics Market based on the below-mentioned segments:

Sexually Transmitted Diseases Diagnostics Market, Type Analysis

• Chlamydia Testing
• Syphilis Testing
• Gonorrhea Testing
• Herpes Simplex Virus Testing
• Human Papilloma Virus Testing
• Human Immunodeficiency Virus Testing
• Chancroid Testing

Sexually Transmitted Diseases Diagnostics Market, Location of Testing Analysis

• Laboratory Testing
• Point of Care Testing

Sexually Transmitted Diseases Diagnostics Market, Testing Devices Analysis

• Laboratory Devices
• Point of Care Devices

Sexually Transmitted Diseases Diagnostics Market, Regional Analysis

·       North America

o   US

o   Canada

o   Mexico

·          Europe

o   Germany

o   Uk

o   France

o   Italy

o   Spain

o   Russia

o   Rest of Europe

·          Asia Pacific

o   China

o   Japan

o   India

o   South Korea

o   Australia

o   Rest of Asia Pacific

·          South America

o   Brazil

o   Argentina

o   Rest of South America

·          Middle East & Africa

o   UAE

o   Saudi Arabia

o   Qatar

o   South Africa

o   Rest of Middle East & Africa